Why would anyone buy out a company that doesn't have one patient worth of data? Because it's in your portfolio?
Also, I'm still concerned about potential immunogenicity from this fusion protein. I've been digging for data but have not found any to alleviate that concern.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.